These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8332203)

  • 21. AIDS research. Debate begins over new vaccine trials.
    Cohen J
    Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.
    Hammonds J; Chen X; Zhang X; Lee F; Spearman P
    Vaccine; 2007 Nov; 25(47):8036-48. PubMed ID: 17936444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Army to test only MicroGeneSys vaccine.
    Science; 1993 Aug; 261(5123):819. PubMed ID: 8346429
    [No Abstract]   [Full Text] [Related]  

  • 25. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):473-9. PubMed ID: 8661397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.
    Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S
    J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):461-72. PubMed ID: 8661396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
    Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technology evaluation: HIVAC-1e.
    Zheng R
    Curr Opin Mol Ther; 1999 Feb; 1(1):121-5. PubMed ID: 11249677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis].
    Chen Y; Garcia R; Baralle FE
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analysis of the principal neutralization site of HIV-1 and vaccine research].
    Okamoto Y; Honda M
    Tanpakushitsu Kakusan Koso; 1997 May; 42(7 Suppl):1201-8. PubMed ID: 9170954
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canada finally begins long journey to an HIV vaccine.
    Silversides A
    CMAJ; 2004 Jun; 170(12):1777. PubMed ID: 15184319
    [No Abstract]   [Full Text] [Related]  

  • 38. Soviet science aide ousted by United States.
    Science; 1966 Sep; 153(3743):1500. PubMed ID: 17749726
    [No Abstract]   [Full Text] [Related]  

  • 39. NIE's Director Ousted, Its Survival in Doubt.
    Holden C
    Science; 1985 Mar; 227(4694):1558-9. PubMed ID: 17795334
    [No Abstract]   [Full Text] [Related]  

  • 40. Dr waxman and ms murdock respond.
    Waxman K; Murdock MA
    West J Med; 1992 Feb; 156(2):210. PubMed ID: 18750863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.